Consistent with prior studies linking tau pathology to glial activation and hypertrophy,55–57 these alterations reflect a pathological shift in astrocyte morphology and behavior, reinforcing the critical role of astrocytes as mediators of AD progression. This evidence concerns the gene MAPT and Alzheimer disease.